(Q37474977)

20 August 2017

1 reference

title

Autoimmunity risk alleles in costimulation pathways (English)

1 reference

20 August 2017

2

David A Hafler

1 reference

20 August 2017

Lisa M Maier

1

1 reference

20 August 2017

publication date

1 May 2009

1 reference

20 August 2017

published in

Immunological Reviews

1 reference

20 August 2017

volume

229

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

322-336

1 reference

Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

The 3' UTR of the human CTLA4 mRNA can regulate mRNA stability and translational efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Risk alleles for multiple sclerosis identified by a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Molecular basis of the dual functions of 2B4 (CD244).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Cutting edge: Regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Characterization of human inducible costimulator ligand expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2009.00777.X

CTLA-4 can function as a negative regulator of T cell activation

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/1074-7613(94)90071-X

Identifiers

DOI

10.1111/J.1600-065X.2009.00777.X

1 reference

20 August 2017

1 reference